The endocannabinoid system refers to a group of neuromodulatory lipids and their receptors that are involved in a variety of physiological processes including appetite, pain-sensation, mood, and memory; it mediates the psychoactive effects of cannabis and, broadly speaking, includes:
- The endogenous arachidonate-based lipids, anandamide (N-arachidonoylethanolamide, AEA) and 2-arachidonoylglycerol (2-AG); these are known as "endocannabinoids" and are physiological ligands for the cannabinoid receptors. Endocannabinoids are all eicosanoids.
- The enzymes that synthesize and degrade the endocannabinoids, such as fatty acid amide hydrolase or monoacylglycerol lipase.
- The cannabinoid receptors CB1 and CB2, two G protein-coupled receptors that are located in the central and peripheral nervous systems.
The endocannabinoid system has been studied using genetic and pharmacological methods. These studies have revealed that cannabinoids act as neuromodulators for a variety of physiological processes, including motor learning, synaptic plasticity, appetite, and pain sensation.
Read more about Endocannabinoid System: Experimental Use of CB1 -/- Phenotype
Famous quotes containing the word system:
“If mothers are to be successful in achieving their child-rearing goals, they must have the inner freedom to find their own value system and within that system to find what is acceptable to them and what is not. This means leaving behind the anxiety, but also the security, of simplistic good-bad formulations and deciding for themselves what they want to teach their children.”
—Elaine Heffner (20th century)